Chinese Drugmakers Target Expiring U.S. Patents
Chinese drugmakers are targeting expiring U.S. drug patents in a bid to accelerate their expansion plans, the South China Morning Post reported....To view the full article, register now.
Already a subscriber? Click here to view full article